Viable tissue repair implants and methods of use

• US 7,901,461 B2
• Filed: 12/05/2003
• Issued: 03/08/2011
• Est. Priority Date: 12/05/2003
• Status: Expired due to Fees

• Current Assignee: DePuy Synthes Products LLC (Johnson & Johnson)
• Original Assignee: Ethicon Incorporated (Johnson & Johnson)
• Inventors: Harmon, Alexander M., Kladakis, Stephanie M., Hwang, Julia
• Primary Examiner(s): Stewart; Alvin J
• Application Number:
  US10/729,046
• Publication Number:
  US 20050125077A1
• Time in Patent Office: 2,650 Days
• Field of Search: 623 2372- 2376, 623/20.32, 623/20.35, 623/16.11, 623/23.5, 623/23.53, 623/23.54, 623/23.58, 623/23.63, 623/1.13, 623 138- 154
• US Class Current: 623/23.72
• CPC Class Codes: A61L 2430/06 for cartilage reconstruction, e.g. meniscus
• CPC Class Codes: A61L 27/3683 subjected to a specific treatment prior to implantation, e.g. decellularising, demineralising, grinding, cellular disruption/non-collagenous protein removal, anti-calcification, crosslinking, supercritical fluid extraction, enzyme treatment
• CPC Class Codes: A61L 27/38 containing added animal cells organs or tissue containing native cells A61L27/36
• CPC Class Codes: A61P 17/02 for treating wounds, ulcers, burns, scars, keloids, or the like
• CPC Class Codes: A61P 19/02 for joint disorders, e.g. arthritis, arthrosis

Abstract

Biocompatible tissue implants are provided for repairing a tissue injury or defect. The tissue implants comprise a biological tissue slice that serves as a source of viable cells capable of tissue regeneration and/or repair. The biological tissue slice can be harvested from healthy tissue to have a geometry that is suitable for implantation at the site of the injury or defect. The harvested tissue slice is dimensioned to allow the viable cells contained within the tissue slice to migrate out and proliferate and integrate with tissue surrounding the injury or defect site. Methods for repairing a tissue injury or defect using the tissue implants are also provided.

Claims

1. A biocompatible tissue implant for repairing a tissue injury or defect, comprising:

(a) an isolated biological tissue slice harvested from healthy tissue, the tissue slice having a geometry suitable for implantation at a tissue site, the tissue slice dimensioned and capable of acting as a cell source that allows viable cells to migrate out of the tissue slice and to proliferate and integrate with tissue at the tissue injury or defect;

(b) at least one minced tissue fragment containing a plurality of viable cells that can migrate from the tissue fragment, wherein the at least one minced tissue fragment is combined with the isolated biological tissue slice; and

(c) a retaining element for securing the tissue slice to the tissue site.

2. The implant of claim 1, wherein the tissue slice comprises autogeneic tissue, allogeneic tissue, xenogeneic tissue, and combinations thereof.

3. The implant of claim 1, wherein the tissue slice is obtained from a tissue type selected from the group consisting of cartilage, meniscus, tendon, ligament, intestinal, stomach, bladder, alimentary, respiratory, genital, liver, dermis, synovium, and combinations thereof.

4. The implant of claim 1, wherein the tissue slice has a thickness less than about 3 mm.

5. The implant of claim 4, wherein the tissue slice has a thickness less than about 1 mm.

6. The implant of claim 5, wherein the tissue slice has a thickness in the range of about 200 μ

m to about 500 μ

m.

7. The implant of claim 4, wherein the tissue slice is configured as a strip.

8. The implant of claim 1, further including a plurality of tissue slices joined together to form a layered implant of a desired size and geometry.

9. The implant of claim 1, wherein the retaining element is selected from the group consisting of fasteners, staples, tissue tacks, sutures, adhesives, and combinations thereof.

10. The implant of claim 9, wherein the retaining element is an adhesive selected from the group consisting of hyaluronic acid, fibrin glue, fibrin clot, collagen gel, collagen-based adhesive, alginate gel, crosslinked alginate, gelatin-resorcin-formalin-based adhesive, mussel-based adhesive, dihydroxyphenylalanine (DOPA)-based adhesive, chitosan, transglutaminase, poly(amino acid)-based adhesive, cellulose-based adhesive, polysaccharide-based adhesive, synthetic acrylate-based adhesives, platelet rich plasma (PRP), platelet poor plasma (PPP), PRP clot, PPP clot, blood, blood clot, polyethylene glycol-based adhesive, Matrigel, Monostearoyl Glycerol co-Succinate (MGSA), Monostearoyl Glycerol co-Succinate/polyethylene glycol (MGSA/PEG) copolymers, laminin, elastin, proteoglycans, and combinations thereof.

11. The implant of claim 1, wherein the at least one minced tissue fragment is delivered in a biological or synthetic hydrogel selected from the group consisting of hyaluronic acid, fibrin glue, fibrin clot, collagen gel, collagen-based adhesive, alginate gel, crosslinked alginate, chitosan, synthetic acrylate-based gels, platelet rich plasma (PRP), platelet poor plasma (PPP), PRP clot, PPP clot, blood, blood clot, Matrigel, agarose, chitin, chitosan, polysaccharides, poly(oxyalkylene), a copolymer of poly(ethylene oxide)-poly(propylene oxide), poly(vinyl alcohol), laminin, elastin, proteoglycans, solubilized basement membrane, or combinations thereof.

12. The implant of claim 1, wherein the at least one minced tissue fragment has a particle size in the range of about 0.1 mm³ to about 2 mm³.

13. The implant of claim 1, further including a biocompatible tissue scaffold.

14. The implant of claim 13, wherein the tissue scaffold is bioresorbable.

15. The implant of claim 13, wherein the tissue scaffold is formed from a material selected from the group consisting of a synthetic polymer, a natural polymer, an injectable gel, a ceramic material, autogeneic tissue, allogeneic tissue, xenogeneic tissue, and combinations thereof.

16. The implant of claim 13, wherein the scaffold further comprises at least one bioactive agent applied thereto.

17. The implant of claim 16, wherein the at least one bioactive agent is selected from the group consisting of growth factors, matrix proteins, peptides, antibodies, enzymes, platelets, platelet rich plasma, glycoproteins, hormones, glycosaminoglycans, nucleic acids, analgesics, viruses, virus particles, cytokines and isolated cells and combinations thereof.

18. The implant of claim 13, further including a plurality of tissue slices and a plurality of tissue scaffolds joined together to form a layered implant of a desired size and geometry.

19. A method for repairing a tissue injury or defect, comprising:

providing;

(i) an isolated biological tissue slice harvested from healthy tissue, having a geometry suitable for implantation at an injury or defect site, and capable of acting as a source of viable cells; and

(ii) at least one minced tissue fragment containing a plurality of viable cells that can migrate from the tissue fragment;

applying the at least one minced tissue fragment to the isolated biological tissue slice to form a biocompatible tissue implant;

delivering the implant to the tissue site to be repaired;

securing the naturally occurring biological tissue slice to the tissue site; and

allowing viable cells to migrate out of the biocompatible tissue implant to proliferate and integrate with tissue at the tissue site.

20. The method of claim 19, wherein the biocompatible tissue implant is in the form of a plurality of tissue slices joined together to form a layered implant of a desired size and geometry.

21. The method of claim 19, further including the step of applying the tissue slice to a biocompatible tissue scaffold to form a composite implant prior to the delivering step, and the step of delivering the implant comprises delivering the composite implant to the tissue site to be repaired.

22. The method of claim 19, further including the step of applying a bioactive agent to the implant either before or after delivery.

23. The method of claim 22, wherein the bioactive agent is selected from the group consisting of growth factors, matrix proteins, peptides, antibodies, enzymes, platelets, platelet rich plasma, glycoproteins, hormones, glycosaminoglycans, nucleic acids, analgesics, viruses, virus particles, cytokines and isolated cells and combinations thereof.

24. The method of claim 19, wherein the step of securing the biocompatible tissue implant to the tissue site includes using a retaining element selected from the group consisting of fasteners, staples, tissue tacks, sutures, adhesives, and combinations thereof.

25. The method of claim 19, wherein the at least one minced tissue fragment is applied in a biological or synthetic hydrogel selected from the group consisting of hyaluronic acid, fibrin glue, fibrin clot, collagen gel, collagen-based adhesive, alginate gel, crosslinked alginate, chitosan, synthetic acrylate-based gels, platelet rich plasma (PRP), platelet poor plasma (PPP), PRP clot, PPP clot, blood, blood clot, Matrigel, agarose, chitin, chitosan, polysaccharides, poly(oxyalkylene), a copolymer of poly(ethylene oxide)-poly(propylene oxide), poly(vinyl alcohol), laminin, elastin, proteoglycans, solubilized basement membrane, or combinations thereof.